Katherine Dobbs, MD
- Assistant Professor, CWRU School of Medicine
- Specialty: Pediatric Infectious Diseases
-
Location:UH Cleveland Medical Center Mather
11100 Euclid Ave
Cleveland, OH 44106
- Call: 216-844-2152
Biography: Katherine Dobbs, MD
Expertise
Certifications & Memberships
- Pediatric Infectious Diseases - American Board of Pediatrics
- Pediatrics - American Board of Pediatrics
Education
Research Fellowship | Pediatric Infectious Diseases
Pediatric Infectious Diseases - Uh Case Medical Center (2015 - 2016)
Fellowship | Pediatric Infectious Diseases
Pediatric Infectious Diseases - Uh Case Medical Center (2012 - 2015)
Residency | Pediatrics
Pediatrics - Boston Medical Center (2009 - 2012)
Medical Education
University Of Pittsburgh School Of Medicine (2009)
Undergraduate
Case Western Reserve University (2003)
About
Katherine R. Dobbs, MD, is a physician in the Division of Pediatric Infectious Diseases. She is Assistant Professor of Pediatrics at Case Western Reserve University School of Medicine.
Dr. Dobbs is board certified in pediatrics and pediatric infectious diseases. Her research interests include innate immunity to malaria and childhood infections of global health significance.
She earned her undergraduate degree summa cum laude from Case Western Reserve University, Cleveland, Ohio, and received her medical degree from the University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania. Dr. Dobbs completed her residency in pediatrics at Boston Medical Center and Boston Children's Hospital in Boston, Massachusetts, and a fellowship in pediatric infectious diseases at Case Western Reserve University and UH Rainbow Babies and Children's Hospital.
Dr. Dobbs joined the UH Rainbow Babies & Children's staff in 2016. She is a member of the American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society.
Research & Publications
Research Interests
Malaria, Innate immunity, Global Health
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Katherine Dobbs did not disclose any Outside Relationships with Industry.